149 related articles for article (PubMed ID: 32944792)
1. Pediatric recurrent Rosai-Dorfman disease with germline heterozygous SLC29A3 and somatic MAP2K1 mutations.
Suryaprakash S; George A; Langenburg S; Savaşan S
Ann Hematol; 2020 Dec; 99(12):2965-2967. PubMed ID: 32944792
[No Abstract] [Full Text] [Related]
2. Rosai-Dorfman Disease and Exocrine Pancreatic Insufficiency in a Patient With a Germline SLC29A3 Mutation.
Blatt J; Parekh P; Powell BC; Fedoriw Y; Reddy I; Montgomery ND
J Pediatr Hematol Oncol; 2021 Jul; 43(5):e689-e691. PubMed ID: 32769566
[TBL] [Abstract][Full Text] [Related]
3. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
Morgan NV; Morris MR; Cangul H; Gleeson D; Straatman-Iwanowska A; Davies N; Keenan S; Pasha S; Rahman F; Gentle D; Vreeswijk MP; Devilee P; Knowles MA; Ceylaner S; Trembath RC; Dalence C; Kismet E; Köseoğlu V; Rossbach HC; Gissen P; Tannahill D; Maher ER
PLoS Genet; 2010 Feb; 6(2):e1000833. PubMed ID: 20140240
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene.
Chouk H; Ben Rejeb M; Boussofara L; Elmabrouk H; Ghariani N; Sriha B; Saad A; H'Mida D; Denguezli M
Hum Genomics; 2021 Oct; 15(1):63. PubMed ID: 34657628
[TBL] [Abstract][Full Text] [Related]
5. Is Rosai-Dorfman disease a reactve process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease.
Matter MS; Bihl M; Juskevicius D; Tzankov A
Virchows Arch; 2017 Oct; 471(4):545-547. PubMed ID: 28597077
[No Abstract] [Full Text] [Related]
6. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.
Garces S; Medeiros LJ; Patel KP; Li S; Pina-Oviedo S; Li J; Garces JC; Khoury JD; Yin CC
Mod Pathol; 2017 Oct; 30(10):1367-1377. PubMed ID: 28664935
[TBL] [Abstract][Full Text] [Related]
7. Generalized pure cutaneous Rosai-Dorfman disease: a link between inflammation and cancer not associated with mitochondrial DNA and SLC29A3 gene mutation?
Zheng M; Bi R; Li W; Landeck L; Chen JQ; Lao LM; Cai SQ; Yao YG; Man XY
Discov Med; 2013 Nov; 16(89):193-200. PubMed ID: 24229736
[TBL] [Abstract][Full Text] [Related]
8. Progressive hearing loss associated with a unique cervical node due to a homozygous SLC29A3 mutation: a very mild phenotype.
Jonard L; Couloigner V; Pierrot S; Louha M; Gherbi S; Denoyelle F; Marlin S
Eur J Med Genet; 2012 Jan; 55(1):56-8. PubMed ID: 21888995
[TBL] [Abstract][Full Text] [Related]
9. Emperipolesis: an additional common histopathologic finding in H syndrome and Rosai-Dorfman disease.
Colmenero I; Molho-Pessach V; Torrelo A; Zlotogorski A; Requena L
Am J Dermatopathol; 2012 May; 34(3):315-20. PubMed ID: 22356918
[TBL] [Abstract][Full Text] [Related]
10. A case of H syndrome showing immunophenotye similarities to Rosai-Dorfman disease.
Avitan-Hersh E; Mandel H; Indelman M; Bar-Joseph G; Zlotogorski A; Bergman R
Am J Dermatopathol; 2011 Feb; 33(1):47-51. PubMed ID: 21178579
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous Rosai Dorfman disease harboring RET and MAP2K1 mutations, successfully treated with methotrexate.
Konstantinou MP; Tournier E
Int J Dermatol; 2022 Nov; 61(11):1409-1411. PubMed ID: 35569068
[No Abstract] [Full Text] [Related]
12. Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition.
Melki I; Lambot K; Jonard L; Couloigner V; Quartier P; Neven B; Bader-Meunier B
Pediatrics; 2013 Apr; 131(4):e1308-13. PubMed ID: 23530176
[TBL] [Abstract][Full Text] [Related]
13. Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease.
Lara-Reyna S; Poulter JA; Vasconcelos EJR; Kacar M; McDermott MF; Tooze R; Doffinger R; Savic S
J Clin Immunol; 2021 Feb; 41(2):441-457. PubMed ID: 33284430
[TBL] [Abstract][Full Text] [Related]
14. Rosai-Dorfman disease involving the central nervous system: seven cases from one institute.
Tian Y; Wang J; Li M; Lin S; Wang G; Wu Z; Ge M; Pirotte BJ
Acta Neurochir (Wien); 2015 Sep; 157(9):1565-71. PubMed ID: 26210482
[TBL] [Abstract][Full Text] [Related]
15. Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.
Shanmugam V; Margolskee E; Kluk M; Giorgadze T; Orazi A
Head Neck Pathol; 2016 Sep; 10(3):394-9. PubMed ID: 26922062
[TBL] [Abstract][Full Text] [Related]
16. Review of Rosai-Dorfman Disease: New Insights into the Pathogenesis of This Rare Disorder.
Cai Y; Shi Z; Bai Y
Acta Haematol; 2017; 138(1):14-23. PubMed ID: 28614806
[TBL] [Abstract][Full Text] [Related]
17. A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variant.
Bolze A; Abhyankar A; Grant AV; Patel B; Yadav R; Byun M; Caillez D; Emile JF; Pastor-Anglada M; Abel L; Puel A; Govindarajan R; de Pontual L; Casanova JL
PLoS One; 2012; 7(1):e29708. PubMed ID: 22238637
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
Paulli M; Bergamaschi G; Tonon L; Viglio A; Rosso R; Facchetti F; Geerts ML; Magrini U; Cazzola M
Br J Haematol; 1995 Oct; 91(2):415-8. PubMed ID: 8547085
[TBL] [Abstract][Full Text] [Related]
19. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
[TBL] [Abstract][Full Text] [Related]
20. Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease.
Venkataraman G; McClain KL; Pittaluga S; Rao VK; Jaffe ES
Am J Surg Pathol; 2010 Apr; 34(4):589-94. PubMed ID: 20216376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
